← all works
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet Infectious Diseases
- Topic
- Antifungal resistance and susceptibility
- Field
- Medicine
- Canadian institutions
- McGill University
- Funders
- National Institute of Allergy and Infectious DiseasesEuropean Research CouncilDeutsche Gesellschaft für EpileptologieBasilea PharmaceuticaAstellas PharmaAgenzia Spaziale ItalianaTeva Pharmaceutical IndustriesMeso Scale DiagnosticsLes Laboratories Pierre FabreDeutsches Zentrum für InfektionsforschungUniversity of LeedsRocheCharitable Leadership FoundationAstraZenecaChiesi FarmaceuticiGlaxoSmithKline AustraliaEuropean CommissionBundesministerium für Bildung und ForschungMerck KGaABayerGilead SciencesDeutsches Zentrum für Lungenforschung3MPfizerCovidienPhysicians' Services Incorporated FoundationNovartis
- Keywords
- MucormycosisGuidelinePosaconazoleMedicineDiseaseIntervention (counseling)Intensive care medicineAmphotericin BMultidisciplinary approachMedical mycologySurgeryAntifungalPathologyDermatologyPolitical science
- Has abstract in OpenAlex
- no